Extracorporeal membrane oxygenation (ECMO) uses cardiopulmonary bypass
technology to provide prolonged cardiac or respiratory support in the
intensive care unit, The use of ECMO for neonatal respiratory failure
is now good evidence-based medicine following publication of the UK C
ollaborative ECMO Trial, but its use in adults and children remains co
ntroversial, In this review the use of ECMO to support paediatric pati
ents with pre-and post-operative cardiac insufficiency is discussed, T
he survival with ECMO in these patients is 43-61%, which is remarkable
in a group of patients who are moribund prior to initiation of ECMO.
(C) Rapid Science Publishers.